معرفی
Benjamin L. Maughan, MD, PharmD serves as Associate Professor in the Division of Medical Oncology within the Department of Internal Medicine at the University of Utah's Huntsman Cancer Institute. His clinical focus centers on genitourinary malignancies with appointments at Farmington Health Center and Huntsman Cancer Institute.
His educational background includes:
- PharmD, cum laude from Idaho State University College of Pharmacy (2004)
- Oncology Pharmacy Residency at St. Luke's Mountain States Tumor Institute (2005)
- MD, cum laude from University of Kentucky College of Medicine (2010)
- Internal Medicine Residency at University of Utah School of Medicine (2013)
- Medical Oncology Fellowship at Johns Hopkins University (2016)
Dr. Maughan's research concentrates on predictive biomarker development and novel therapeutics for genitourinary cancers, particularly metastatic prostate, kidney, and bladder cancers. His work explores immune therapy combinations including checkpoint inhibitors with radiation therapy (radium-223), oncolytic viruses (MVA-brachyury), and targeted therapies (cabozantinib). He investigates truncated androgen receptors (AR-V7) and tumor suppressor loss (PTEN/Rb) as biomarkers in prostate cancer.
His recent publications demonstrate strong focus on biomarker validation, immunotherapy combinations, and real-world treatment patterns across genitourinary malignancies, with particular emphasis on renal cell carcinoma and prostate cancer subtypes. Current research trends show increasing integration of genomic profiling with clinical outcomes assessment.
Scientific recognition includes:
- Huntsman Cancer Institute Translational Scholar Award (2019)
- SWOG Young Investigator Training Course selection (2019)
Dr. Maughan leads clinical trials including a SWOG study exploring novel treatments for metastatic papillary kidney cancer. His patient care philosophy emphasizes detailed explanation and compassionate communication, reflected in consistently high patient satisfaction scores (4.9/5 from 256 reviews). He holds board certifications in Internal Medicine and Medical Oncology from the American Board of Internal Medicine.
